Entropy Neurodynamics (ENP) Fundamentals 2026 — Revenue Analysis | SniperIQ
Entropy Neurodynamics (ENP) is a AU-listed Healthcare company in Biotechnology with a market capitalization of A$59M, trading at A$0.04 on the ASX. This SniperIQ fundamentals page covers Entropy Neurodynamics's valuation, profitability (net margin 0.0%), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Entropy Neurodynamics's market cap?
Entropy Neurodynamics (ENP) has a market capitalization of approximately A$59M, trading at A$0.04 on the ASX. Market cap moves with the live share price.
What is Entropy Neurodynamics's P/E ratio?
Entropy Neurodynamics's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 6.8x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Entropy Neurodynamics?
Entropy Neurodynamics runs a net profit margin of 0.0%, a gross margin of 0.0%, and an operating margin of 0.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
Does Entropy Neurodynamics pay a dividend?
Entropy Neurodynamics does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Entropy Neurodynamics financially healthy?
Entropy Neurodynamics carries a debt-to-equity ratio of 0.08x and a current ratio of 7.78x, with a market beta of -0.36. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Entropy Neurodynamics a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Entropy Neurodynamics (ENP) the key facts are: market cap A$59M, 52-week range 0.025-0.046. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Entropy Neurodynamics's full fundamentals live
Get Entropy Neurodynamics's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.